首页> 外文OA文献 >Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions 2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug ABT-578 Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

【2h】

Late Safety, Efficacy, and Cost-Effectiveness of a Zotarolimus-Eluting Stent Compared With a Paclitaxel-Eluting Stent in Patients With De Novo Coronary Lesions 2-Year Follow-Up From the ENDEAVOR IV Trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug ABT-578 Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

机译：从头到尾进行ENDEAVOR IV试验的2年随访（美敦力药物的随机，对照试验），从左至右冠状动脉洗脱支架与紫杉醇洗脱支架相比，紫杉醇洗脱支架的后期安全性，有效性和成本效益。 ABT-578 De Novo原生冠状动脉病变中的洗脱冠状动脉支架系统与红豆杉紫杉醇-洗脱冠状动脉支架系统）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Leon Martin B.; Kandzari David E.; Eisenstein Eric L.; Anstrom Kevin J.; Mauri Laura; Cutlip Donald E.; Nikolsky Eugenia; OShaughnessy Charles; Overlie Paul A.; Kirtane Ajay J.; McLaurin Brent T.; Solomon Stuart L.; Douglas John S.; Popma Jeffrey J.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). [J] . Kandzari DE, Mauri L, Popma JJ, JACC. Cardiovascular interventions . 2011,第5期

机译：佐他莫司和西罗莫司洗脱支架的近期临床疗效。 ENDEAVOR III（美敦力努力药物（ABT-578）洗脱冠状动脉支架系统与赛诺莫司洗脱冠状动脉支架系统在De Novo天然冠状动脉病变中的随机对照试验）的5年随访。
2. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). [J] . Kandzari DE, Mauri L, Popma JJ, JACC. Cardiovascular interventions . 2011,第5期

机译：佐他莫司和西罗莫司洗脱支架的近期临床疗效。 ENDEAVOR III（美敦力努力药物（ABT-578）洗脱冠状动脉支架系统与赛诺莫司洗脱冠状动脉支架系统在De Novo天然冠状动脉病变中的随机对照试验）的5年随访。
3. A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. [J] . Leon MB, Mauri L, Popma J Journal of the American College of Cardiology . 2010,第6期

机译：ENDEAVOR IV试验从头开始的天然冠脉病变中ENDEAVOR佐他莫司洗脱支架与TAXUS紫杉醇洗脱支架的随机比较。
4. The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients: Final 5-year follow-up of the Endeavor Japan study [C] . Saito S. International Congress on Coronary Artery Disease. . 2013

机译：日本患者促进Zotarolimus洗脱冠军支架的临床评价：最后5年的日本研究
5. Therapeutic self -assembled monolayers for coronary stent based drug delivery systems. [D] . Mani, Gopinath. 2007

机译：用于冠状动脉支架的药物输送系统的自组装治疗性单层。
6. A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program [O] . Dominic J Allocco, Louis A Cannon, Amy Britt, 2010

机译：TAXUS元素紫杉醇洗脱冠状动脉支架系统治疗新发冠状动脉病变的安全性和有效性的前瞻性评估：PERSEUS临床程序的设计和统计方法
7. Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug ABT-578 Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions) [O] . Eisenstein Eric L., Leon Martin B., Kandzari David E., 2009

机译：ENDEAVOR III试验（美敦力药物ABT-578洗脱冠状动脉支架系统的随机对照试验）与Endovor Zotarolimus洗脱支架与Cypher Sirolimus洗脱支架相比3年结果的长期临床和经济分析从头开始的原生冠状动脉病变中的Cypher Sirolimus洗脱冠状动脉支架系统

著录项

相似文献

相关主题

期刊订阅